Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
about
Idiopathic pulmonary fibrosis.Non-steroid agents for idiopathic pulmonary fibrosisImmunomodulatory agents for idiopathic pulmonary fibrosisRedox mechanisms in age-related lung fibrosisLeukocytes: The Double-Edged Sword in FibrosisTime-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosisOxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signalingEpithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.Sputum myeloperoxidase in chronic obstructive pulmonary disease.Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infectionDouble-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability.Bioluminescence imaging of myeloperoxidase activity in vivo.Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.Oxidants/antioxidants in idiopathic pulmonary fibrosis.Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport.Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosisAntioxidant responses to oxidant-mediated lung diseases.Attenuation of oxidant-induced lung injury by 21-aminosteroids (lazaroids): correlation with the mRNA expression for E-selectin, P-selectin, ICAM-1, and VCAM-1.Superoxide dismutases in the lung and human lung diseases.Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinaseIdiopathic pulmonary fibrosis: current and future treatment options.Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cellsRepeated exposures to enzyme-generated oxidants cause alveolitis, epithelial hyperplasia, and fibrosis in hamstersOxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.Molecular and cellular mechanisms of pulmonary fibrosis.Vitamins and respiratory disease: antioxidant micronutrients in pulmonary health and disease.Epithelial-mesenchymal interactions in pulmonary fibrosis.Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapyEvolving concepts of apoptosis in idiopathic pulmonary fibrosis.Extracellular superoxide dismutase in pulmonary fibrosisOxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosisCurrent and emerging drugs for idiopathic pulmonary fibrosis.Targeting NOX enzymes in pulmonary fibrosisOxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosisThe antioxidant response element and oxidative stress modifiers in airway diseases.Protective Effect of Caffeic Acid Phenethyl Ester (CAPE) on Amiodarone-Induced Pulmonary Fibrosisin Rat
P2860
Q21202895-15F558FE-ED7E-418E-93C4-478C0E58F059Q24235478-7E761A7E-712A-44E4-8A9B-B33D517ED6D3Q24248714-2756D5E8-E85C-47A8-A026-86DB1B7C425BQ26743421-F68F4933-3983-4436-8F04-BD0614C74BDAQ26777122-9FC35AD7-2A39-4F37-801A-4D03581ACC86Q28388130-60211210-C24E-47DC-9CE5-9A07DF583419Q28393242-41ABB4E5-3BFE-4350-93CD-3B2F9DF36C9BQ30484036-F4CD5D98-A19F-4D57-9B89-73E1D019A72DQ33592946-11EABA9E-6698-4B83-AF85-B8D6847B5E90Q33602209-6ECA68C3-A5DF-493B-A863-EEA62D92A5CBQ33605247-309E4E0E-1B88-40FA-9079-14C8D8DE1049Q33657810-4D8E1A34-03F2-4578-B82A-9C1F67889F67Q33700977-6C7BD7E4-F1C1-44DB-9D33-6BF0E83F1BAFQ33754678-CFD29ED8-1E27-444D-A297-BD7E0AAC903BQ33821300-6BBF4D0A-C19A-4AC3-BE65-23C6C75B115FQ34124953-36A14350-A9FB-436A-853F-482B6957C2C7Q34213002-7C6D00AA-60F2-402A-A601-1C1E5E6EE20FQ34735411-B1254C5F-F4A8-4173-801D-5A55863199C5Q35031437-2BD24EC6-50B1-46D5-A541-0BB4D22CA85CQ35149483-545965E7-69D2-48A6-938B-CBA5278A4F55Q35533314-696E641D-0D3A-4802-8A4C-CEFF0CAEAF75Q35588784-2FB914EA-5F75-4269-8B21-0A7D1494C418Q35627863-E79A1D80-7135-4510-891F-CE79E0971286Q35771616-52391DCF-5E1A-4F35-B684-70C4BF7EF3CAQ35831459-2025C8C9-53CD-4A63-AF41-29CF975367ADQ36128020-426EE71E-59EE-4FAE-B53C-1150ACD52A0AQ36215313-CC1B4AC3-DB88-4327-ACAE-3841D6C567D0Q36237168-C351AF0D-E4C4-4BC8-9669-F9EDC82C926DQ36325132-8652257C-94E8-4EE5-B5AB-21D05BD77C2FQ36427136-A57A05F7-16D5-43EC-8B04-0F799ECFB5E3Q36440438-44987734-F9D2-4071-84AD-4D2F0529AD0BQ36493966-A4E43BCD-D3EF-4DAB-B88B-4F54EA07DA73Q36534222-27A8FB49-B9A8-4811-A06C-B4CF365AE91FQ36847599-732EC248-9433-4113-9B8C-486D48575E69Q36940906-C322E145-0704-4170-A08D-EEADF0583994Q36989934-0D83AA16-D6D5-4C49-8432-450B65D827EAQ37008372-4D32A055-3051-4B54-BE17-F6282D958CE4Q37081908-8EE8ADA2-CCC7-4874-A159-27A27A6B5B09Q37239760-DB1E7A72-361B-49BE-8469-12A79849BB98Q37310758-041BE1A7-B35D-449F-90D9-6CFBDFC0B71F
P2860
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@ast
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@en
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@nl
type
label
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@ast
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@en
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@nl
prefLabel
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@ast
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@en
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P356
P1476
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
@en
P2093
P2860
P304
P356
10.1172/JCI113005
P407
P577
1987-06-01T00:00:00Z